Such analysis provided the confirmation of FGFR-2 expression trend in thyroid samples (0.89 fold in hyperplastic tissue, P = 0.07; 0.07 fold in adenoma samples, P<0.01; 0.24 fold in carcinoma samples, P<0.01). Here, FGFR2 is linked to thyroid gland disorder.